Omnicell, Inc. (OMCL)

Market Cap	1.28B
Revenue (ttm)	1.15B
Net Income (ttm)	-20.37M
Shares Out	45.92M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	25.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	374,418
Open	27.27
Previous Close	27.13
Day's Range	27.27 - 28.28
52-Week Range	25.69 - 77.14
Beta	0.76
Analysts	Buy
Price Target	43.25 (+55.24%)
Earnings Date	May 2, 2024

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing syst...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,650
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL

Analyst Forecast

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is $43.25, which is an increase of 55.24% from the latest price.

Price Target

$43.25

(55.24% upside)

Analyst Consensus: Buy